divislab glp-1 novo nordisk relation Finds Medicare Patients Prefer Pill Over Shot for Weight Loss Novo Nordisk: Intense Competition Within

The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust your workout routine when taking a GLP-1.

Nausea affects up to 40% of GLP-1 users during initial treatment, but simple dietary and lifestyle adjustments can significantly reduce discomfort

A new KFF analysis estimates that 3.8 million Medicare Part D enrollees could qualify for the Medicare GLP-1 Bridge program, which began July 1 and provides temporary coverage of GLP-1s for weight reduction for eligible beneficiaries through December 2027.

Los pacientes que toman medicamentos GLP-1 como Ozempic y Zepbound podran estar en riesgo de sufrir complicaciones respiratorias durante la ciruga

This review covers everything you need to know.

We asked: why